tirzepatide novo nordisk FDA Grants a New Indication for Obesity Management Lilly's new monthly Zepbound pen

The truth sits somewhere in the middle, and getting it wrong can mean confiscated medication, degraded peptide, or a missed dose that throws off your entire protocol

Not everyone taking Wegovy would be a suitable candidate for switching medications

Tatarkiewicz K., Smith P

At follow-up three months after initial presentation, the patient already had approximately 15 pounds of weight loss

Guidelines: the 2023 International PCOS Guideline positions GLP-1RAs as practical weight-loss tools for obese women with PCOS but emphasizes that they must be used within a framework of continuous, effective contraception throughout the treatment period, and should not be considered a routine intervention for weight or metabolic management during pregnancy ( Lactation: although preliminary data suggest extremely low milk transfer and no clear adverse signals in infants (163), the overall evidence remains insufficient